June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.See Full Update

US drug overdose deaths top 109,000 in the past year

Published 06/14/2023, 11:58 AM
Updated 06/14/2023, 12:52 PM
© Reuters. FILE PHOTO: Paramedics display a dose of the opioid overdose reversal drug Narcan, or Naloxone Hydrochloride, in an ambulance in Peabody, Massachusetts, U.S., August 8, 2017.   REUTERS/Brian Snyder/File Photo

By Nandhini Srinivasan and Khushi Mandowara

(Reuters) - More than 109,000 Americans died from drug overdoses in the 12-month period ending January 2023, a slight increase from the previous year, according to provisional data from the U.S. Centers for Disease Control and Prevention (CDC) released on Wednesday.

The figure is up 0.7% from 108,825 overdoses recorded in the 12-month period ending January 2022, according to U.S. data.

The increase comes despite a push by President Joe Biden's administration for action to tackle drug addiction and overdoses.

The Biden administration in May imposed sanctions on 17 people and entities based in China and Mexico it accused of enabling production of counterfeit fentanyl-laced pills. Illicit fentanyl has played an outsized role in the U.S. opioid crisis and drug overdoses.

The U.S. drug overdose death toll crossed the 100,000-mark for the first time in 2021, as the COVID pandemic disrupted medical care and increased mental health problems. The effect was exacerbated by the widespread availability of lethal drugs such as fentanyl, which is 50 times stronger than heroin and increasingly mixed in with other illegal drugs.

During the pandemic, rates of mental illness, depression and anxiety went up dramatically, and people increasingly began to switch to substances, said Tom Britton, CEO of American Addiction Centers.

U.S. drug overdose deaths rose 13.7% between January 2021 and January 2022 and by 31.4% in the prior 12 months at the height of the pandemic.

But the surge in overdose deaths began before the pandemic took hold due to abuse of prescription opioid painkillers and illegal drugs like heroin.

Stacey McKenna, senior fellow at the R Street Institute, a Washington, D.C.-based independent think tank, said the crackdown on fentanyl and other addictive drugs could be having the opposite of the intended affect.

"There's this iron law of prohibition that the harder you crack down on the supply, the more likely you are to get a more potent supply or a more dangerous supply," McKenna said.

© Reuters. FILE PHOTO: Paramedics display a dose of the opioid overdose reversal drug Narcan, or Naloxone Hydrochloride, in an ambulance in Peabody, Massachusetts, U.S., August 8, 2017.   REUTERS/Brian Snyder/File Photo

The CDC noted that the latest numbers represent an estimate to include underreporting and cases pending investigation.

(This story has been corrected to say that overdose deaths were up 0.7% from 108,825, not 107,764, for the 12-month period ending January 2022 in paragraph 2)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.